Huawei Announces Vigan G1 CGM Approved as Class III Medical Device
11/13/2026 — 11/13, 15:21·1 sources (all)·1 reports (all)
Key takeaways
- Huawei has announced its first continuous glucose monitor, Vigan G1, which has received Class III medical device registration from China's N…
- Heat index
- 85
- All sources
- 1
- All reports
- 1
- First seen
- 6 hours ago
Reports on this story headlines open the original
Huawei has officially announced its first continuous glucose monitor, the Weigan G1, after securing a Class III medical device registration certificate from China's NMPA. The device offers continuous glucose monitoring linked to smartphones and smartwatches, marking Huawei's entry into clinical-grade health tracking.
IT之家AI score 54
Other stories people are talking about
- Heat index 2236Nvidia stock plunges after Jensen Huang resigns, with retail investors buying the dip35 sources
- Heat index 1463RisingGoogle Opens Gemini 4 Hydrogen to All Users as High-Speed Model21 sources
- Heat index 1429SurgeJensen Huang exits as NVIDIA CEO, leadership vacuum lingers16 sources
- Heat index 785SurgeAnthropic hires gas supply lead to power data center expansion after IPO10 sources
- Heat index 673SurgeMicrosoft races to fix global outage hitting Outlook, Teams and Copilot8 sources
How is heat calculated?About the methodHide
Heat counts how many independent sources covered a story in the last 48 hours: one source counts once no matter how many posts it published, decaying with a 24-hour half-life. What ranks first is what many people are talking about.
This page aggregates public feeds. Headlines and summaries are machine-organized and remain the property of the original authors; verify important facts at the source. If you believe a headline or summary infringes your rights, email the contact address in the footer with the page URL and basis of your claim, and we will remove or replace it after review.
- Surge
- Discussion rising fast
- New
- First report within 6 hours
- Rising
- Still gathering discussion